The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Allen Oliff sits on this spectrum.
This scientist: 157 publications — 30th percentile
30% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 1,028 publications or more.
The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Allen Oliff sits on this spectrum.
This scientist: 62 D-Index — 46th percentile
46% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 167 D-Index or more.
Allen Oliff is affiliated with GlaxoSmithKline in the United States, contributing to the field of biochemistry, genetics, and molecular biology. Their research integrates molecular biology techniques to explore mechanisms fundamental to development and disease.
The scientist's work primarily focuses on several key topics:
Allen Oliff has contributed to the publication landscape with articles appearing in reputable journals, including at least one publication in ACS Medicinal Chemistry Letters. The available record highlights a paper titled "Discovery of Orally Bioavailable Ligand Efficient Quinazolindiones as Potent and Selective Tankyrases Inhibitors", published in 2021.
This publication aligns with the scientist's interest in targeting pathways relevant to cancer biology, specifically through small-molecule inhibitors that may influence signaling cascades such as those involving tankyrases.
Frequent collaborators of Allen Oliff include researchers such as:
The interdisciplinary approach spans molecular biology as a central subfield, reflecting the emphasis on understanding cellular processes at a molecular level. This focus supports investigations into both fundamental biology and translational applications related to cancer and metabolism.
Allen Oliff;Deborah Defeo-Jones;Mark Boyer;Douglas Martinez
NE Kohl;SD Mosser;SJ deSolms;EA Giuliani
N E Kohl;C A Omer;M W Conner;N J Anthony
Jackson B. Gibbs;Allen Oliff;Nancy E. Kohl
Laura Sepp-Lorenzino;Zhenping Ma;Elaine Rands;Nancy E. Kohl
Jackson B. Gibbs;Allen Oliff
J. B. Gibbs;D. L. Pompliano;S. D. Mosser;E. Rands
Robert B. Lobell;Charles A. Omer;Marc T. Abrams;Hema G. Bhimnathwala
A I Oliff;G L Hager;E H Chang;E M Scolnick
M Ivey-Hoyle;R Conroy;H E Huber;P J Goodhart
Mark M. Moasser;Laura Sepp-Lorenzino;Nancy E. Kohl;Allen Oliff
G C Prendergast;J P Davide;S J deSolms;E A Giuliani
David C. Heimbrook;Allen I. Oliff;Steven M. Stirdivant
Fattaey Ar;Helin K;Dembski Ms;Dyson N
Jackson B. Gibbs;Allen Oliff
Rebecca E. Barrington;Mark A. Subler;Elaine Rands;Charles A. Omer
Sandra Ruscetti;Lenora Davis;John Feild;Allen Oliff
S K Chattopadhyay;A I Oliff;D L Linemeyer;M R Lander
P S Huang;D R Patrick;G Edwards;P J Goodhart
Ramon Mangues;Teresa Corral;Nancy E. Kohl;William F Symmans
If you think any of the details on this page are incorrect, let us know.
Rowan University
Chemnitz University of Technology
Imec
Columbia University
National Institutes of Health
National Institutes of Health
Leiden University Medical Center
Yale University
University of Cambridge
University of Freiburg
Indian Institute of Technology Kharagpur
University of Technology Malaysia
Beijing University of Chemical Technology
Blue Hexagon Inc.
James Cook University
University of Helsinki